𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis

✍ Scribed by Schwartz, Steven; Brater, D Craig; Pound, David; Green, Paula K; Kramer, William G; Rudy, David

Book ID
109845187
Publisher
Nature Publishing Group
Year
1993
Tongue
English
Weight
961 KB
Volume
54
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics of paroxetine in patien
Pharmacokinetics of paroxetine in patients with cirrhosis
✍ K. Dalhoff; T. P. Almdal; K. Bjerrum; S. Keiding; H. Mengel; J. Lund πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 419 KB

In a 14-day multiple-dose study the pharmacokinetics of paroxetine was investigated in 12 patients with alcoholic cirrhosis and in 6 subjects without liver disease. The dose of 20-30 mg paroxetine daily was adjusted to the reduction in liver function, as assessed by the galactose elimination capacit

Pharmacokinetics of diacerein in patient
Pharmacokinetics of diacerein in patients with liver cirrhosis
✍ O. Magnard; K. Louchahi; M. Tod; O. Petitjean; P. Molinier; L. Berdah; G. Perret πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 388 KB πŸ‘ 1 views

The pharmacokinetics of diacerein following a single oral dose of 50 mg was studied in 12 healthy volunteers, 10 patients with a mild liver cirrhosis (Child Pugh's grade A), and 6 patients with a more severe liver cirrhosis (Child Pugh's grade B to C). Statistical analysis using a Kruskal-Wallis tes